[TOP STORY] The appetite for GLP-1 drugs grows

Loading player...

‘The nature of the beast is yes, these drugs come off patent; the demand is there and someone could produce it more cheaply’, Integral Asset Management’s Keith McLachlan points out.

24 Jan 2025 3AM English South Africa Business News · Business

[TOP STORY] Smaller turkeys on the Christmas table?

Independent economist John Loos expects the ongoing Middle East conflict to lead to postponable end-of-year spending as well as an interest-rate hike.

4 Sep 2AM 6 min

PGM stocks: Still worth a look on weakness

Faheema Adia from Momentum unpacks Discovery's strong results as the bank hits profit and Implats financials as PGM miners continue to print money, but are any of them worth buying? John Loos on the risk to the year-end consumer spending as the Iranian war drags on. Simon's thoughts on his…

4 Sep 1AM 19 min

[TOP STORY] Motus 2026 results show the benefit of Chinese imports

CEO Ockert Janse van Rensburg reports that Tata is again doing very well and last year 57% of vehicles imported actually came from India – the likes of Suzuki, Toyota, Hyundai, Kia and Renault.

3 Sep 2AM 7 min

Will Woolies say goodbye to fashion?

Alyssa Viljoen, MD of Merchant West Investments, unpacks the Woolies and Aspen results. Cashbuild CEO Werner de Jager discusses rising revenue, lower profits, the Malawi exit and the acquisition of three Amper Alles stores. Plus, Motus CEO Ockert Janse van Rensburg on full-year results as cheap Chinese imports continue to…

3 Sep 1AM 21 min

[TOP STORY] Shoprite aims to become ‘your everyday store’

CEO Pieter Engelbrecht talks 2026 results as the retailer pushes into coffee and telco. Smart diversification, or 'taste and see'?

2 Sep 2AM 6 min